Anti-D104A/ DEFB104A/ BD-4 functional antibody

Anti-D104A/ DEFB104A/ BD-4 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to DEFB104A/DEFB104A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0856-Ab-1/ GM-Tg-hg-SE0856-Ab-2Anti-Human DEFB104A monoclonal antibodyHuman
GM-Tg-rg-SE0856-Ab-1/ GM-Tg-rg-SE0856-Ab-2Anti-Rat DEFB104A monoclonal antibodyRat
GM-Tg-mg-SE0856-Ab-1/ GM-Tg-mg-SE0856-Ab-2Anti-Mouse DEFB104A monoclonal antibodyMouse
GM-Tg-cynog-SE0856-Ab-1/ GM-Tg-cynog-SE0856-Ab-2Anti-Cynomolgus/ Rhesus macaque DEFB104A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0856-Ab-1/ GM-Tg-felg-SE0856-Ab-2Anti-Feline DEFB104A monoclonal antibodyFeline
GM-Tg-cang-SE0856-Ab-1/ GM-Tg-cang-SE0856-Ab-2Anti-Canine DEFB104A monoclonal antibodyCanine
GM-Tg-bovg-SE0856-Ab-1/ GM-Tg-bovg-SE0856-Ab-2Anti-Bovine DEFB104A monoclonal antibodyBovine
GM-Tg-equg-SE0856-Ab-1/ GM-Tg-equg-SE0856-Ab-2Anti-Equine DEFB104A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0856-Ab-1/ GM-Tg-hg-SE0856-Ab-2; GM-Tg-rg-SE0856-Ab-1/ GM-Tg-rg-SE0856-Ab-2;
GM-Tg-mg-SE0856-Ab-1/ GM-Tg-mg-SE0856-Ab-2; GM-Tg-cynog-SE0856-Ab-1/ GM-Tg-cynog-SE0856-Ab-2;
GM-Tg-felg-SE0856-Ab-1/ GM-Tg-felg-SE0856-Ab-2; GM-Tg-cang-SE0856-Ab-1/ GM-Tg-cang-SE0856-Ab-2;
GM-Tg-bovg-SE0856-Ab-1/ GM-Tg-bovg-SE0856-Ab-2; GM-Tg-equg-SE0856-Ab-1/ GM-Tg-equg-SE0856-Ab-2
Products NameAnti-DEFB104A monoclonal antibody
Formatmab
Target NameDEFB104A
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-DEFB104A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0856-Ag-1Recombinant multi-species D104A/ DEFB104A/ BD-4 protein


    Target information

    Target IDGM-SE0856
    Target NameDEFB104A
    Gene ID140596
    Gene Symbol and SynonymsBD-4,DEFB-4,DEFB104,DEFB104A,DEFB4,hBD-4
    Uniprot AccessionQ8WTQ1
    Uniprot Entry NameD104A_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000176782
    Target ClassificationN/A

    The target: DEFB104A, gene name: DEFB104A, also named as BD-4, DEFB-4, DEFB104, DEFB4, hBD-4. Defensins form a family of antimicrobial and cytotoxic peptides made by neutrophils. Defensins are short, processed peptide molecules that are classified by structure into three groups: alpha-defensins, beta-defensins and theta-defensins. All beta-defensin genes are densely clustered in four to five syntenic chromosomal regions. Chromosome 8p23 contains at least two copies of the duplicated beta-defensin cluster. This duplication results in two identical copies of defensin, beta 104, DEFB104A and DEFB104B, in head-to-head orientation. This gene, DEFB104A, represents the more centromeric copy. [provided by RefSeq, Oct 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.